coagulopathy

(redirected from Coagulation defects)
Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.

coagulopathy

 [ko-ag″u-lop´ah-the]
any disorder of blood coagulation.
consumption coagulopathy disseminated intravascular coagulation.

co·ag·u·lop·a·thy

(kō'ag-yū-lop'ă-thē),
A disease affecting the coagulability of the blood.

coagulopathy

/co·ag·u·lop·a·thy/ (ko-ag″u-lop´ah-the) any disorder of blood coagulation.
consumption coagulopathy  disseminated intravascular coagulation.

coagulopathy

[kō·ag′yəlop′əthē]
a pathologicalondition that reduces the ability of the blood to coagulate, resulting in uncontrolled bleeding.

coagulopathy

Hematology A clotting defect in which bleeding does not stop in the usual time period Etiology Hemophilia, drug-induced defects–eg, aspirin, thrombocytopenia, liver disease, Von Willebrand's disease. See Consumption coagulopathy, DIC, Leukemic coagulopathy.

co·ag·u·lop·a·thy

(kō-ag'yū-lop'ă-thē)
A disease affecting the coagulability of the blood.

Coagulopathy

A disorder in which blood is either too slow or too quick to coagulate (clot).
Mentioned in: Cerebral Palsy

coagulopathy

any disorder of blood coagulation. See also hemophilia.

consumption coagulopathy
a bleeding tendency due to a reduction in clotting factors caused by their utilization. See also disseminated intravascular coagulation.
disseminated intravascular coagulopathy (DIC)
see disseminated intravascular coagulation.
hepatic coagulopathy
impaired synthesis of most clotting factors, including factors I, II, V, VII, IX and X, as well as other substances involved in the fibrinolytic system, in severe liver disease can cause significant abnormalities in coagulation.
References in periodicals archive ?
SPS was the sole hereditary thrombophilic abnormality in 1 of the patients with a confirmed diagnosis of SPS; the remaining 5 patients had other inherited coagulation defects, in addition to SPS.
As compared to hereditary coagulation defects, data on the role of SPS in arterial or venous thrombosis is scarce.
5% of the entire study cohort]); in the other 5 patients SPS coexisted with other well known hereditary coagulation defects, which is similar to previous studies that reported that 83% (14) and 33% (15) of patients with SPS presented with additional congenital prothrombotic conditions.